BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Vemurafenib

An indole sulfonamide compound and inhibitor of BRAF KINASES that is used for the treatment of unresectable or metastatic MELANOMA.

298+ PubMed studies analyzed · 10 RCTs · Evidence Score: 50.7

Research Domains

Vemurafenib has been studied across 14 research domains including 🔬 Oncology, ✨ Skin & Hair, 🧬 Hormones, ⏳ Longevity & Aging, 🔬 Inflammation. The primary research focus is 🔬 Oncology with 71% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Vemurafenib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

darapladib
12 shared targets
Benzethonium
14 shared targets
Ticagrelor
11 shared targets
2-Methoxyestradiol
11 shared targets
Dequalinium
13 shared targets
tyrphostin
13 shared targets
Afatinib
15 shared targets
ly
7 shared targets
plx
16 shared targets
Dasatinib
25 shared targets
Loading evidence profile...

This evidence profile for Vemurafenib is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.